Nikolina Lauc is the CEO and Co-founder of GlycanAge, a leading startup in the health-tech and longevity space whose technology was developed over 20 years of research supported by 40 million in European grant funding. Utilizing the largest proprietary dataset of human glycome, GlycanAge is pioneering advanced blood biomarkers for the prediction of age-related diseases.